Search
01/07/2022
Measuring the functional impact of cognitive impairment in Huntington's disease
Horta-Barba, A, Martinez-Horta, S, Perez-Perez, J, Sampedro, F, Puig-Davi, A, Pagonabarraga, J, Kulisevsky, J. Measuring the functional impact of cognitive impairment in Huntington's disease. JOURNAL OF NEUROLOGY. 2022; 269(7)DOI:10.1007/s00415-021-10955-2. PMID:35061089. IF:6.000(Q1/2D).
21/02/2022
Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus
Stocchi, F, Antonini, A, Berg, D, Bergmans, B, Jost, W, Katzenschlager, R, Kulisevsky, J, Odin, P, Valldeoriola, F, Chaudhuri, KR. Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus. npj Parkinsons Disease. 2022; 8(1)DOI:10.1038/s41531-022-00277-z. PMID:35190544. IF:8.700(Q1/1D).
31/01/2022
Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders
Sampedro, F, Camara, E, Kulisevsky, J. Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.843440. PMID:35173676. IF:3.400(Q2/5D).
21/01/2022
Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data
Abdelnour, C, Ferreira, D, van de Beek, M, Cedres, N, Oppedal, K, Cavallin, L, Blanc, F, Bousiges, O, Wahlund, LO, Pilotto, A, Padovani, A, Boada, M, Pagonabarraga, J, Kulisevsky, J, Aarsland, D, Lemstra, AW, Westman, E. Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-021-00946-w. PMID:35063023. IF:9.000(Q1/1D).